WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Life-Extending drug access granted for rare blood disorder patients
Disease control TEMPORARILY_NOT_AVAILABLEThis program provides continued access to the drug nipocalimab for people with warm autoimmune hemolytic anemia (wAIHA) who benefited from it in a previous 28-week study. It is for participants who showed improvement in their hemoglobin levels and completed the prior study withou…
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial aims to tame rare blood disorder
Disease control OngoingThis study is testing an investigational drug called M281 (nipocalimab) for adults with warm autoimmune hemolytic anemia (wAIHA), a condition where the immune system mistakenly attacks red blood cells. The main goal is to see if the drug can safely and durably improve hemoglobin …
Matched conditions: WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC